630 RIGHT HERE ON KCCI BY THE OWNERS OF A MULTI-MILLION DOLLAR, 55 PLUS HOUSING DEVELOPMENT IN WAUKEE HAVE FILED FOR BANKRUPTCY. NOW. CONTRACT INVESTORS AND BUYERS TRYING TO MOVE IN ARE WONDERING WHAT ...
Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results